Ram Melkote, Founder and CEO , Sedara, Inc
Improved patient engagement is at the helm of preventive healthcare. While the need for patient engagement has been focused on chronic disease management/avoidance of acute episodes and post-discharge care, on a broader spectrum, payers are now investing in Population Health Management and Prevention Technologies. Readmission occurs due to patients/caregivers not understanding discharge instructions, not adhering to a regimen or ineffective and untimely communication about their condition. Mobile solutions available in the market that are used to address such healthcare impediments are generic and need heavy customizations to make them work for physicians and care teams. Finally, the absence of reliable/quality support for co-morbidities due to the unavailability of customized mobile applications that support near real-time biometric information from patients suffering from multiple conditions needs resolution.
Sedara solves the problems mentioned above by offering a personalized medicine platform that helps manage chronic care, reduce readmissions and emergency visits, prevent disease, leverage provider resources, and enhance patient and physician satisfaction. The product is thereby clearly differentiated, defended, and is patent pending.
Headquartered at San Francisco, Sedara provides platform-based engaging apps capable of acting as a proxy for physicians and care teams, educating and comforting patients, keeping close tabs on their progress and pain, and gathering critical biometric data. Moreover, the apps run on Android/iPhone and interface to Bluetooth monitoring devices like BP/ Blood Sugar/EKG/weight. Sedara’s mobile apps are customized at the individual physician practice level to patients and conditions, including joint replacement, diabetes, heart disease, etc. With its signature patent-pending technology (via a drag and drop modeler), the company creates, customizes, and deploys cross-platform native mobile apps in minutes.
We believe in passing the baton to both the patient and the care team to take control as they ask questions and interact with the patient
Furthermore, each of the custom apps that are developed can be rolled out to both Android and iPhone platforms as native applications – as opposed to existing cross-platform generative tools that create less robust hybrid apps.
Interestingly, with the Sedara platform, multiple apps can be deployed/ integrated to the same patient device while running seamlessly as a single app at the user interface. Physicians and staff can see time series reports on all interactions with the patient. The app created by the modeler runs on the mobile phone of the patient and follows protocol and logic that has been created by the physician/care team. “We believe in passing the baton to both the patient and the care team to take control as they ask questions and interact with the patient,” states Ram Melkote, the Founder and CEO at Sedara. The apps include a chatbot that answers patient’s questions with multimedia based answers through texts, images, and videos. Effectively, the chatbot successfully passes the baton to the patient. The patient can control the narrative by asking free form questions on the application.
What differentiates Sedara’s platform from a more generic patient engagement solution is that the customized apps are fully native, user-friendly, and resilient to network issues, and entirely accessible for Bluetooth Devices. Powered by Predictive Analytics and Machine Learning effectively to spot trends, Sedara’s platform-based solutions come with full support for multiple co-morbidities. Physicians/staff can see reports based on interactions with the patient. Additionally, the product can easily scale within the same organization. Thus, multiple use cases—such as surgery follow-up, wound care, post-emergency care, blood pressure regimen, medication changes, oncology follow-up, and many more—are possible with this flexible technology.
Quickly carving a niche in the patient engagement arena, Sedara will start utilizing its system integrators (SI) and independent software vendor (ISV) channel partners effectively as an embedded/licensed, white-label partner. Consequently, larger health institutions can implement the company’s products without any hassle. “Having garnered positive early feedback from over 50 physicians and patients, we are currently negotiating pilots with larger Providers, Payers, and University Medical Centers,” concludes Melkote.